Synaptiq Therapeutics Launches with Acquisition of Clinical-Stage SYN-001 Program

Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8013, an Antibody Drug Conjugate Targeting CD25 for the Treatment of Advanced Solid Tumors

Touching Hearts at Home Reaches 100 Franchise Locations, Marking a Milestone in Its Continued Growth

New Free Tool Lets Anyone Measure Their "Voice Score" in 30 Seconds - No App, No Account As remote work and video calls drive rising vocal strain, Voicelyt offers instant, data-backed insight into vocal health

SimX Launches Scenario Editor, a No-Code Tool for Customizing VR Medical Simulations

New Economic Modeling Shows Improved Lyme Disease Diagnostics Could Cut U.S. Lyme Healthcare Costs by 41.5%

Beckman Coulter Diagnostics Launches Fully Automated Urinalysis System to Meet Rising Testing Volumes

ACLM's Lifestyle Medicine Residency Curriculum earns 2026 AAMSE Profiles of Excellence Award

PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS

Medgene offers first-ever cattle vaccine to address Theileria

Accord BioPharma Announces Commercial Availability of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)

SALAD AND GO MEETS DEMAND FOR AFFORDABLE, HEALTHY FAST FOOD WITH MENU 2.GO

Maverix Names Carla Jung Chief Executive Officer to Lead Next Phase of Growth

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Ribo publie des résultats positifs suite à l'essai de Phase 2a réalisé sur le vortosiran - Premières données cliniques au monde sur l'inhibition du facteur XI par pARNi après administration de plusieurs doses chez des patients atteints de coronaropathie

Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara Facility

Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors

Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026

Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C

Towner County Medical Center Reduces Downtime and Improves Clinical Workflows with Epson Business Printing Solutions

West Reports Second-Quarter 2026 Results

Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy

Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH

Video: USF Athletics and Tampa General Hospital Unveil New Football Uniforms Featuring Tampa General Hospital Patch

Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting

Ribo veröffentlicht positive Daten aus der Phase-2a-Studie zu Vortosiran - weltweit erste klinische Daten zur siRNA-vermittelten FXI-Hemmung nach wiederholter Verabreichung bei Patienten mit koronarer Herzkrankheit

/C O R R E C T I O N -- Inizio/

Community Access, Mega Group and Public Officials Celebrate Groundbreaking of 213-Unit Affordable and Supportive Housing Development in the Bronx

Accord Specialty Pharmacy Named Finalist in MMIT's 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Target Hospitality Announces Closing of Secondary Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares